World J Gastroenterol
March 2019
Background: Despite the advent of biological drugs, conventional therapy continues to be used in moderate to severe inflammatory bowel disease (MS-IBD). This study hypothesized that as a standard of treatment and the primary alternative to biologics, conventional therapy should present robust effectiveness results in IBD outcomes.
Aim: To investigate the effectiveness of conventional therapy for MS-IBD.